With 35 years of experience in the preclinical drug R&D market, I am a business development expert who delivers new technology penetration and commercialisation solutions for life science companies. I have a proven track record of introducing novel drug discovery technologies that have improved the efficiency and reduced costs for drug discovery scientists, as well as enabling the benefit of POC medical devices for clinical trials.Most recently, I was the Director of Business Development, Early Discovery Services at Reaction Biology Europe GmbH, a company that offers contract research to support the drug discovery community. I was responsible for developing and executing the business strategy, generating new leads and opportunities, and managing key accounts and partnerships in Europe. I also contributed to the company's vision and mission of discovering answers through preclinical research and providing high-quality and reliable services to clients. My goal is to leverage my skills and expertise to drive innovation and growth in the drug discovery field and to help biotechnology companies achieve their objectives.